A carregar...
Conjugate of Doxorubicin to Albumin-Binding Peptide Outperforms Aldoxorubicin
Short circulation time and off-target toxicity are the main challenges faced by small-molecule chemotherapeutics. To overcome these shortcomings, an albumin-binding peptide conjugate of chemotherapeutics is developed that binds specifically to endogenous albumin and harnesses its favorable pharmacok...
Na minha lista:
| Publicado no: | Small |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8114561/ https://ncbi.nlm.nih.gov/pubmed/30756483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.201804452 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|